Overview

Predicting Ovarian Response in Artificial Insemination With Low Stimulation

Status:
Unknown status
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This large prospective multi-center cohort study aims to identify patient's characteristics that significantly influence ovarian response to mild stimulation with a fixed dose of 75 IU recombinant FSH.
Details
Lead Sponsor:
Isala
Collaborator:
Merck Serono International SA
Treatments:
Follicle Stimulating Hormone
Hormones